TPP2a bromide
TPP2a bromide is a thioredoxin reductase (TrxR) inhibitor with an IC50 value of 1.16 μM, and also acts as a TrxR-specific fluorescent probe with environment-sensitive fluorescence. TPP2a bromide selectively forms covalent interactions with subcellular mitochondrial TrxR, thereby modifying its Sec498 residue. TPP2a bromide can increase the level of reactive oxygen species (ROS) in cells and induce mitochondrial apoptosis in cancer cells. TPP2a bromide exhibits enhanced cytotoxicity against cancer cell lines. TPP2a bromide can be used in research related to cervical cancer, lung cancer, etc.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1838592-80-5
- 分子式: C47H52BrO5P
- 分子量:807.79
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
IC50 & Target
[1]|
TrxR 1.16 μM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HeLa | IC50 |
0.91 μM
|
Cytotoxicity against human HeLa cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
Cytotoxicity against human HeLa cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
|
26653078 |
| MDA-MB-231 | IC50 |
1.09 μM
|
Cytotoxicity against human MDA-MB-231 cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
Cytotoxicity against human MDA-MB-231 cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
|
26653078 |
| Bel-7402 | IC50 |
1.56 μM
|
Cytotoxicity against human Bel-7402 cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
Cytotoxicity against human Bel-7402 cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
|
26653078 |
| PC-3 | IC50 |
1.82 μM
|
Cytotoxicity against human PC3 cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
Cytotoxicity against human PC3 cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
|
26653078 |
| SW480 | IC50 |
2.01 μM
|
Cytotoxicity against human SW480 cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
Cytotoxicity against human SW480 cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
|
26653078 |
| A549 | IC50 |
2.77 μM
|
Cytotoxicity against human A549 cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
Cytotoxicity against human A549 cancer cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
|
26653078 |
体外実験
TPP2a (5 min at 25 °C) potently inhibits purified mammalian TrxR with an IC50 of 1.16 μM[1].
TPP2a (24 h) potently inhibits mitochondrial TrxR isolated from HeLa cells with an IC50 of 1.44 μM, a 16.8-fold improvement over its parental compound 2a[1].
TPP2a selectively and covalently binds to the Sec498 residue of TrxR, as demonstrated by fluorescent labeling of TrxR in HeLa cell lysates and purified TrxR samples, and dose-dependent inhibition of BIAM labeling at pH 6.5[1].
TPP2a (1.0 μM; 6 h) selectively localizes to the mitochondria of living HeLa cells, as shown by colocalization with MitoTracker Red in confocal microscopy images[1].
TPP2a, when coupled with a Cu2+-based nonspecific signal quenching strategy, acts as a selective fluorescent probe for TrxR, exhibiting specific fluorescence in purified TrxR samples, TrxR-depleted HeLa cell lysates, and living HeLa cells with intact mitochondrial TrxR[1].
TPP2a (48 h) potently inhibits the growth of HeLa, PC3, A549, Bel-7402, MDA-MB-231, and SW480 human cancer cell lines with IC50 values ranging from 0.91 μM to 2.77 μM, with HeLa cells being the most sensitive[1].
TPP2a (0.1-2.5 μM; 6 h) dose-dependently increases superoxide anion and hydrogen peroxide levels in HeLa cells after 6 h of incubation, with maximal effects observed at 2.5 μM[1].
TPP2a (0.1-2.5 μM; 24-48 h) dose-dependently induces apoptosis in HeLa cells via the intrinsic mitochondrial pathway, with 96.80% total apoptotic cells observed at 2.5 μM, accompanied by decreased mitochondrial membrane potential, altered Bcl-2 family protein expression, and activation of caspase and PARP cleavage[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HeLa cells
-
Concentration:0.1 μM; 0.5 μM; 1 μM; 2.5 μM
-
Incubation Time:24 h (cell cycle analysis); 48 h (apoptosis detection); dose-dependent for Western blot and mitochondrial membrane potential measurements)
-
Result:Induced apoptosis in a dose-dependent manner, with total early and late apoptotic cell populations of 4.44%, 21.46%, 45.27%, and 96.80% at 0.1, 0.5, 1, and 2.5 μM, respectively.
Increased the sub-G0 cell population in a dose-dependent manner.
Decreased mitochondrial membrane potential in a dose-dependent manner.
Upregulated pro-apoptotic Bax and Bad protein levels.
Downregulated anti-apoptotic Bcl-2 and Bcl-xl protein levels.
Activated the caspase cascade, increasing cleaved caspase 9, cleaved caspase 3, cleaved caspase 7, and cleaved PARP levels.
-
Cell Line:HeLa cells
-
Concentration:1.0 μM
-
Incubation Time:6 h
-
Result:Colocalized with MitoTracker Red in the mitochondria of HeLa cells, confirming selective targeting of subcellular mitochondria.
化学情報
-
CAS 番号 1838592-80-5
-
分子量 807.79
-
分子式 C47H52BrO5P
-
SMILES
O=C(/C=C(/C=C/C1=CC=C(C)O1)O)/C=C/C2=CC=C(C(OC)=C2)OCCCCCCCCCC[P+](C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5.[Br-]
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)